Total Payments
$5,597
2024 Payments
$330.76
Companies
28
Transactions
373
Medicare Patients
8,571
Medicare Billing
$691,894
Payment Breakdown by Category
Food & Beverage$5,575 (99.6%)
Education$21.17 (0.4%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $5,575 | 370 | 99.6% |
| Education | $21.17 | 3 | 0.4% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Janssen Pharmaceuticals, Inc | $915.59 | 70 | $0 (2024) |
| PFIZER INC. | $908.49 | 80 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $678.23 | 43 | $0 (2024) |
| E.R. Squibb & Sons, L.L.C. | $468.43 | 31 | $0 (2024) |
| Amgen Inc. | $466.69 | 26 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $438.78 | 30 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $329.28 | 20 | $0 (2024) |
| Boston Scientific Corporation | $270.57 | 17 | $0 (2022) |
| Merck Sharp & Dohme LLC | $179.19 | 9 | $0 (2024) |
| Medtronic Vascular, Inc. | $175.84 | 4 | $0 (2020) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $330.76 | 16 | Novartis Pharmaceuticals Corporation ($100.99) |
| 2023 | $216.40 | 11 | Novartis Pharmaceuticals Corporation ($53.95) |
| 2022 | $579.94 | 38 | Janssen Pharmaceuticals, Inc ($122.78) |
| 2021 | $391.52 | 23 | Amgen Inc. ($67.25) |
| 2020 | $572.80 | 39 | Janssen Pharmaceuticals, Inc ($157.71) |
| 2019 | $1,106 | 82 | PFIZER INC. ($199.24) |
| 2018 | $1,354 | 94 | PFIZER INC. ($292.78) |
| 2017 | $1,045 | 70 | Novartis Pharmaceuticals Corporation ($162.55) |
All Payment Transactions
373 individual payment records from CMS Open Payments — Page 1 of 15
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/11/2024 | Merck Sharp & Dohme LLC | VERQUVO (Drug), VERQUVO | Food and Beverage | In-kind items and services | $27.47 | General |
| Category: CARDIOVASCULAR | ||||||
| 11/06/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $20.08 | General |
| Category: DIABETES | ||||||
| 10/23/2024 | Merck Sharp & Dohme LLC | VERQUVO (Drug), VERQUVO | Food and Beverage | In-kind items and services | $22.64 | General |
| Category: CARDIOVASCULAR | ||||||
| 09/25/2024 | E.R. Squibb & Sons, L.L.C. | CAMZYOS (Drug) | Food and Beverage | Cash or cash equivalent | $16.44 | General |
| Category: Cardiovascular | ||||||
| 08/19/2024 | Merck Sharp & Dohme LLC | VERQUVO (Drug), VERQUVO | Food and Beverage | In-kind items and services | $14.28 | General |
| Category: CARDIOVASCULAR | ||||||
| 07/31/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug), ENTRESTO | Food and Beverage | In-kind items and services | $24.52 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 07/17/2024 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $18.40 | General |
| Category: Cardiology | ||||||
| 06/18/2024 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug), LEQVIO | Food and Beverage | In-kind items and services | $28.56 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 05/21/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $13.64 | General |
| Category: Obesity | ||||||
| 05/13/2024 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug), LEQVIO | Food and Beverage | In-kind items and services | $22.03 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 05/01/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $14.59 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 04/17/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug), ENTRESTO | Food and Beverage | In-kind items and services | $25.88 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 04/11/2024 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $20.89 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 02/11/2024 | Medtronic, Inc. | COBALT DR MRI SURESCAN (Device) | Food and Beverage | In-kind items and services | $24.42 | General |
| Category: Implantable Cardioverter Defibrillators (ICDs) | ||||||
| 02/09/2024 | PFIZER INC. | ELIQUIS (Drug), PAXLOVID, NURTEC ODT | Food and Beverage | In-kind items and services | $14.04 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 01/24/2024 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $22.88 | General |
| Category: Cardiology | ||||||
| 12/05/2023 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $16.50 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 11/08/2023 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $20.42 | General |
| Category: DIABETES | ||||||
| 10/11/2023 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $21.64 | General |
| Category: Cardiology | ||||||
| 08/09/2023 | PFIZER INC. | VYNDAQEL (Drug) | Food and Beverage | In-kind items and services | $19.98 | General |
| Category: CARDIOVASCULAR | ||||||
| 07/11/2023 | AstraZeneca Pharmaceuticals LP | BRILINTA (Drug) | Food and Beverage | In-kind items and services | $17.56 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 07/06/2023 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | LifeVest (Device) | Food and Beverage | Cash or cash equivalent | $18.72 | General |
| Category: Electromedical and Electrotherapeutic Apparatus | ||||||
| 06/07/2023 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $21.02 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 04/03/2023 | Philips Electronics North America Corporation | (5091) Amb Mon & Diag Und (Device) | Food and Beverage | Cash or cash equivalent | $22.30 | General |
| Category: Medical Device | ||||||
| 02/22/2023 | Edwards Lifesciences Corporation | Edwards SAPIEN 3 Ultra Transcatheter Heart Valve (Device) | Food and Beverage | In-kind items and services | $25.03 | General |
| Category: Transcatheter Heart Valves | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 14 | 1,798 | 2,389 | $414,878 | $134,619 |
| 2022 | 17 | 2,138 | 2,924 | $544,614 | $182,697 |
| 2021 | 20 | 2,292 | 3,236 | $817,396 | $193,870 |
| 2020 | 23 | 2,343 | 3,404 | $758,782 | $180,708 |
Total Patients
8,571
Total Services
11,953
Medicare Billing
$691,894
Procedure Codes
84
All Medicare Procedures & Services
84 procedure records from CMS Medicare Utilization — Page 1 of 4
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 361 | 533 | $135,915 | $44,631 | 32.8% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Office | 2023 | 185 | 187 | $74,725 | $23,893 | 32.0% |
| 78452 | Nuclear medicine studies of heart muscle at rest and with stress and spect | Office | 2023 | 51 | 51 | $47,583 | $15,436 | 32.4% |
| A9500 | Technetium tc-99m sestamibi, diagnostic, per study dose | Office | 2023 | 52 | 101 | $25,957 | $9,416 | 36.3% |
| J2785 | Injection, regadenoson, 0.1 mg | Office | 2023 | 44 | 176 | $19,008 | $8,431 | 44.4% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Facility | 2023 | 137 | 140 | $22,190 | $7,211 | 32.5% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2023 | 60 | 101 | $19,796 | $6,634 | 33.5% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 62 | 62 | $20,398 | $6,586 | 32.3% |
| 93010 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | Facility | 2023 | 429 | 606 | $23,077 | $3,492 | 15.1% |
| 93015 | Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | Office | 2023 | 70 | 70 | $9,730 | $3,161 | 32.5% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 190 | 198 | $5,742 | $1,863 | 32.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 27 | 28 | $5,012 | $1,584 | 31.6% |
| 93356 | Heart muscle strain imaging | Office | 2023 | 78 | 79 | $1,975 | $1,490 | 75.4% |
| 93294 | Evaluation of single, dual, multiple lead or leadless pacemaker system, remote up to 90 days | Office | 2023 | 16 | 18 | $1,080 | $296.27 | 27.4% |
| 93296 | Evaluation of single, dual, multiple lead or leadless pacemaker system or implantable defibrillator system, remote up to 90 days | Office | 2023 | 24 | 27 | $1,323 | $292.64 | 22.1% |
| 76376 | 3d radiographic procedure | Office | 2023 | 12 | 12 | $1,368 | $201.96 | 14.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 452 | 740 | $186,893 | $61,388 | 32.8% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Office | 2022 | 207 | 212 | $91,213 | $28,572 | 31.3% |
| 78452 | Nuclear medicine studies of heart muscle at rest and with stress and spect | Office | 2022 | 71 | 71 | $69,355 | $24,384 | 35.2% |
| A9500 | Technetium tc-99m sestamibi, diagnostic, per study dose | Office | 2022 | 72 | 143 | $36,217 | $14,200 | 39.2% |
| J2785 | Injection, regadenoson, 0.1 mg | Office | 2022 | 60 | 240 | $25,920 | $11,642 | 44.9% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Facility | 2022 | 186 | 188 | $28,200 | $10,209 | 36.2% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 85 | 85 | $27,902 | $9,127 | 32.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2022 | 60 | 105 | $20,580 | $6,789 | 33.0% |
| 93015 | Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | Office | 2022 | 81 | 81 | $11,259 | $3,930 | 34.9% |
About Dr. Fritz Roc, M.D
Dr. Fritz Roc, M.D is a Cardiovascular Disease healthcare provider based in Syracuse, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/14/2005. The National Provider Identifier (NPI) number assigned to this provider is 1790784411.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Fritz Roc, M.D has received a total of $5,597 in payments from pharmaceutical and medical device companies, with $330.76 received in 2024. These payments were reported across 373 transactions from 28 companies. The most common payment nature is "Food and Beverage" ($5,575).
As a Medicare-enrolled provider, Roc has provided services to 8,571 Medicare beneficiaries, totaling 11,953 services with total Medicare billing of $691,894. Data is available for 4 years (2020–2023), covering 84 distinct procedure/service records.
Ad
Practice Information
- Specialty Cardiovascular Disease
- Other Specialties Nuclear Cardiology
- Location Syracuse, NY
- Active Since 07/14/2005
- Last Updated 07/24/2012
- Taxonomy Code 207RC0000X
- Entity Type Individual
- NPI Number 1790784411
Products in Payments
- XARELTO (Drug) $915.59
- ELIQUIS (Drug) $709.15
- CHANTIX (Drug) $614.55
- ENTRESTO (Drug) $507.17
- PRADAXA (Drug) $278.19
- Corlanor (Drug) $251.59
- Repatha (Biological) $215.10
- BRILINTA (Drug) $204.24
- VERQUVO (Drug) $179.19
- LEQVIO (Drug) $171.06
- JARDIANCE (Drug) $160.59
- Amplia MRI (Device) $110.00
- FARXIGA (Drug) $103.49
- PRALUENT (Drug) $94.19
- EMBLEM (Device) $68.90
- Livalo (Drug) $59.34
- LifeVest (Device) $48.41
- Consulta (Device) $45.04
- Anthem CRT Pacemaker (Device) $38.87
- Vascepa (Drug) $37.94
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Cardiovascular Disease Doctors in Syracuse
Saverio Barbera, Md, MD
Cardiovascular Disease — Payments: $41,547
Cardiovascular Disease $41,547
Dr. Kiran Devaraj, M.d, M.D
Cardiovascular Disease — Payments: $36,432
Cardiovascular Disease $36,432
Dr. Nikhil Joshi, M.d, M.D
Cardiovascular Disease — Payments: $28,775
Cardiovascular Disease $28,775
Dr. Ankur Kalra, Md, MD
Cardiovascular Disease — Payments: $26,848
Cardiovascular Disease $26,848
Dr. Tristan Petrie, Md, MD
Cardiovascular Disease — Payments: $18,178
Cardiovascular Disease $18,178
Michael Gabris, Md Facc, MD FACC
Cardiovascular Disease — Payments: $11,834
Cardiovascular Disease $11,834